SK10902001A3 - Spôsob izolácie kyseliny pseudomonovej z kultivačného bujónu obsahujúceho komplex kyseliny pseudomonovej - Google Patents

Spôsob izolácie kyseliny pseudomonovej z kultivačného bujónu obsahujúceho komplex kyseliny pseudomonovej Download PDF

Info

Publication number
SK10902001A3
SK10902001A3 SK1090-2001A SK10902001A SK10902001A3 SK 10902001 A3 SK10902001 A3 SK 10902001A3 SK 10902001 A SK10902001 A SK 10902001A SK 10902001 A3 SK10902001 A3 SK 10902001A3
Authority
SK
Slovakia
Prior art keywords
pseudomonic acid
extract
isobutyl acetate
water
acid
Prior art date
Application number
SK1090-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Istvan Barta
Aniko Tegdes
Valeria Szell
Csaba Szabo
Nee Arvai Edit Nagy
Vilmos Keri
David Leonov
Ildiko Lang
Nee Igloy Margit Bidlo
Gyula Jerkovich
Janos Salat
Original Assignee
Biogal Gy�Gyszergy�R Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gy�Gyszergy�R Rt. filed Critical Biogal Gy�Gyszergy�R Rt.
Publication of SK10902001A3 publication Critical patent/SK10902001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1090-2001A 1999-02-03 2000-02-03 Spôsob izolácie kyseliny pseudomonovej z kultivačného bujónu obsahujúceho komplex kyseliny pseudomonovej SK10902001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11844799P 1999-02-03 1999-02-03
PCT/US2000/002824 WO2000046388A1 (en) 1999-02-03 2000-02-03 Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth

Publications (1)

Publication Number Publication Date
SK10902001A3 true SK10902001A3 (sk) 2002-04-04

Family

ID=22378653

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1090-2001A SK10902001A3 (sk) 1999-02-03 2000-02-03 Spôsob izolácie kyseliny pseudomonovej z kultivačného bujónu obsahujúceho komplex kyseliny pseudomonovej

Country Status (23)

Country Link
US (1) US6245921B1 (pt)
EP (1) EP1147210A4 (pt)
JP (1) JP2002535996A (pt)
KR (1) KR20010112258A (pt)
CN (1) CN1345377A (pt)
AU (1) AU771214B2 (pt)
BG (1) BG105775A (pt)
BR (1) BR0009178A (pt)
CA (1) CA2360840A1 (pt)
CZ (1) CZ20012725A3 (pt)
HK (1) HK1041294A1 (pt)
HR (1) HRP20010570A2 (pt)
HU (1) HUP0105286A3 (pt)
IL (1) IL144678A0 (pt)
IS (1) IS6034A (pt)
MX (1) MXPA01007805A (pt)
NO (1) NO20013790L (pt)
PL (1) PL349153A1 (pt)
SK (1) SK10902001A3 (pt)
TR (1) TR200102232T2 (pt)
WO (1) WO2000046388A1 (pt)
YU (1) YU55501A (pt)
ZA (1) ZA200106057B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000046389A1 (en) * 1999-02-03 2000-08-10 Biogal Gyogyszergyar Rt Process for the preparation of pseudomonic acid a antibiotic by microbiological method
AU2002345856A1 (en) * 2001-06-21 2003-01-08 Biogal Gyogyszergyar Rt Metabolic controlled fermentation process for pseudomonic acid production
DE20220885U1 (de) * 2001-12-28 2004-06-24 BIOGAL Gyógyszergyár Rt. Kristallines und amorphes Mupirocin-Calcium
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
WO2005117837A1 (en) * 2004-06-01 2005-12-15 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Process for preparation of amorphous form of a drug
US7619102B2 (en) 2005-02-21 2009-11-17 Axellia Pharmaceuticals Aps Purification of mupirocin
GB2441328A (en) * 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium
US8268975B2 (en) * 2009-04-03 2012-09-18 Dow Agrosciences Llc Demulsification compositions, systems and methods for demulsifying and separating aqueous emulsions
CN104370896A (zh) * 2013-11-29 2015-02-25 江苏汉邦科技有限公司 一种纯化假单孢菌素的方法
CN103820369B (zh) * 2014-03-07 2015-11-18 浙江瑞邦药业有限公司 一种萤光假单胞菌及其应用
CN109053707B (zh) * 2018-09-19 2021-08-17 福建康鸿生物科技有限公司 一种莫匹罗星的提纯方法
CN110823649A (zh) * 2019-10-21 2020-02-21 河南中烟工业有限责任公司 一种卷烟主流烟气中有机酸的收集方法和检测方法
US20230312540A1 (en) * 2020-08-25 2023-10-05 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd Method for extracting mupirocin
CN116867905A (zh) * 2021-02-07 2023-10-10 杭州中美华东制药有限公司 一种莫匹罗星的发酵方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1395907A (en) 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
JPS5270083A (en) 1975-12-04 1977-06-10 Yoshitomi Pharmaceut Ind Ltd Manufacture of an antibiotics, trans-pseudomonic acid
CA1103264A (en) * 1977-09-30 1981-06-16 Norman H. Rogers Purification of pseudomonic acid
CA1115699A (en) 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
IS1606B (is) * 1991-05-07 1996-10-18 Sankyo Company Limited Aðferð til framleiðslu nýs sýkladrepandi efnasambands Thiomarinol, fengið með ræktun Alteromanas rava SANK 73390

Also Published As

Publication number Publication date
BR0009178A (pt) 2001-11-20
MXPA01007805A (es) 2003-06-04
ZA200106057B (en) 2002-07-24
US6245921B1 (en) 2001-06-12
AU771214B2 (en) 2004-03-18
EP1147210A1 (en) 2001-10-24
IS6034A (is) 2001-08-01
HRP20010570A2 (en) 2002-08-31
NO20013790D0 (no) 2001-08-02
CN1345377A (zh) 2002-04-17
KR20010112258A (ko) 2001-12-20
BG105775A (en) 2002-03-29
HK1041294A1 (zh) 2002-07-05
IL144678A0 (en) 2002-06-30
EP1147210A4 (en) 2004-06-02
JP2002535996A (ja) 2002-10-29
AU2980200A (en) 2000-08-25
CA2360840A1 (en) 2000-08-10
CZ20012725A3 (cs) 2002-03-13
WO2000046388A1 (en) 2000-08-10
YU55501A (sh) 2003-07-07
NO20013790L (no) 2001-10-02
TR200102232T2 (tr) 2002-02-21
PL349153A1 (en) 2002-07-01
HUP0105286A3 (en) 2003-03-28
HUP0105286A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
SK10902001A3 (sk) Spôsob izolácie kyseliny pseudomonovej z kultivačného bujónu obsahujúceho komplex kyseliny pseudomonovej
Takahashi et al. Altemicidin, a new acaricidal and antitumor substance II. Structure determination
DE60121150T2 (de) Verfahren zur herstellung von ansamitocin
AU661469B2 (en) Bridged cyclic ketal derivatives
JPH04217986A (ja) 抗高コレステロール血症薬
DE4320023A1 (de) Holotyp-Stamm Aspergillus obscurus und Verfahren zur Herstellung von µ,£-Di-(hydroxy)-7-[1,2,6,7,8,8a-hexa-(hydro)-2,6-di-(methyl)-8-(2'-{methyl}-butyryloxy)-naphthalin-1-yl]-heptansäure-£-lacton{Mevinolin} und/oder µ,5-Di-(hydroxy)-7-[1,2,6,7,8,8a-hexa-(hydro)-2,6-di-(methyl)-8-(2'-{mehtyl}-butyryloxy)-naphthalin-1-yl]-heptansäure
JPH032867B2 (pt)
EP0318849A2 (de) Manumycin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
HUT70524A (en) Novel makrolides and their use
EP0196628B1 (de) Ein neues Ansamycin-Antibiotikum, ein mikrobielles Verfahren zu seiner Herstellung und seine Verwendung als Arzneimittel
EP1856111B1 (en) Purification of mupirocin
EP0116150A2 (en) Pharmaceutically active heterocyclic compounds containing at least four ring-nitrogen atoms, their preparation and fermentation broths of ASPERGILLUS ALLIACEUS ATCC 20655 and 20656
DE3234203C2 (pt)
DE60203937T2 (de) Herstellung von trans-kondensierte 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivaten
JPS6259701B2 (pt)
EP0068680B1 (en) Antibiotics
FR2518546A1 (fr) Dihydro- et tetrahydromonacolines l, leur procede de preparation et leur application en therapeutique
DE2746209C2 (pt)
PL205567B1 (pl) Sposoby krystalizacji kwasów hydroksykarboksylowych
EP0469480A2 (de) Verfahren zur stereoselektiven Herstellung von 5-substituierten delta-Lactonen und deren Verwendung
US5281533A (en) Scytophycins-producing Scytonema pseudohofmanni microorganisms
JP3795604B2 (ja) Gex1化合物
KR0130473B1 (ko) 새로운 항생물질, 베나노마이신 a와 b 및 덱실오실베나노마이신 b와 이들의 제조 방법과 용도
JPH0556332B2 (pt)
WO2002026744A1 (fr) Derives de mpc1001